Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fonatsch

Showing results (91-100 of 157) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|May 1, 1995
Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AMLC Sperling, T Büchner, U Creutzig, et al.
Blood|June 1, 1992
The translocation (6;9) (p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical featuresD Soekarman, M von Lindern, S Daenen, et al.
Blood|October 15, 1995
Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulationsD Haase, M Feuring-Buske, S Könemann, et al.
Blood|March 15, 1996
The abnormal eosinophils are part of the leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils (AML M4Eo) and carry the pericentric inversion 16: a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridizationT Haferlach, M Winkemann, H Löffler, et al.
Annals of Hematology|April 1, 1993
Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative GroupT Haferlach, W Gassmann, H Löffler, et al.
Cancer Research|June 15, 1994
Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous systemT Pietsch, T Scharmann, C Fonatsch, et al.
British Journal of Haematology|July 1, 1989
Recombinant human interferon (IFN) alpha-2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti-interferon antibodiesM Freund, P von Wussow, H Diedrich, et al.
Blut|March 1, 1988
T-cell acute childhood lymphoblastic leukemia with chromosome 14 q 11 anomaly: a morphologic, immunologic, and cytogenetic analysis of 10 patientsF Lampert, J Harbott, J Ritterbach, et al.
Human Mutation|February 22, 2007
Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruptionK Wimmer, X Roca, H Beiglböck, et al.
European Journal of Clinical Investigation|May 21, 2009
Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12E Porpaczy, M Bilban, G Heinze, et al.
Pageof 16

Showing results (91-100 of 157) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|May 1, 1995
Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AMLC Sperling, T Büchner, U Creutzig, et al.
Blood|June 1, 1992
The translocation (6;9) (p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical featuresD Soekarman, M von Lindern, S Daenen, et al.
Blood|October 15, 1995
Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulationsD Haase, M Feuring-Buske, S Könemann, et al.
Blood|March 15, 1996
The abnormal eosinophils are part of the leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils (AML M4Eo) and carry the pericentric inversion 16: a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridizationT Haferlach, M Winkemann, H Löffler, et al.
Annals of Hematology|April 1, 1993
Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative GroupT Haferlach, W Gassmann, H Löffler, et al.
Cancer Research|June 15, 1994
Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous systemT Pietsch, T Scharmann, C Fonatsch, et al.
British Journal of Haematology|July 1, 1989
Recombinant human interferon (IFN) alpha-2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti-interferon antibodiesM Freund, P von Wussow, H Diedrich, et al.
Blut|March 1, 1988
T-cell acute childhood lymphoblastic leukemia with chromosome 14 q 11 anomaly: a morphologic, immunologic, and cytogenetic analysis of 10 patientsF Lampert, J Harbott, J Ritterbach, et al.
Human Mutation|February 22, 2007
Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruptionK Wimmer, X Roca, H Beiglböck, et al.
European Journal of Clinical Investigation|May 21, 2009
Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12E Porpaczy, M Bilban, G Heinze, et al.
Pageof 16